Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,156 | 26,684 | 20,745 | 14,032 | 12,674 |
| Marketable Securities | 19,113 | 8,207 | N/A | 11,125 | 16,487 |
| Other current assets | 989 | 1,735 | 461 | 815 | 1,083 |
| TOTAL | $41,258 | $36,626 | $21,206 | $25,972 | $30,244 |
| Non-Current Assets | |||||
| PPE Net | 67 | 83 | 87 | 100 | 115 |
| Other Non-Current Assets | 694 | 772 | 847 | 1,081 | 1,312 |
| TOTAL | $761 | $855 | $934 | $1,181 | $1,427 |
| Total Assets | $42,019 | $37,481 | $22,140 | $27,153 | $31,671 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,105 | 592 | 64 | 1,490 | 844 |
| Accrued Expenses | 3,076 | 2,888 | 4,556 | 4,486 | 5,135 |
| TOTAL | $4,181 | $3,480 | $4,620 | $5,976 | $5,979 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 349 | 441 | 532 | 621 | 709 |
| TOTAL | $351 | $445 | $536 | $624 | $710 |
| Total Liabilities | $4,532 | $3,925 | $5,156 | $6,600 | $6,689 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,294 | 1,289 | 856 | 710 | 694 |
| Common Shares | 19 | 16 | 11 | 11 | 10 |
| Retained earnings | -420,119 | -414,792 | -421,390 | -417,400 | -412,444 |
| Other shareholders' equity | 27 | 30 | 33 | 31 | 28 |
| TOTAL | $37,487 | $33,556 | $16,984 | $20,553 | $24,982 |
| Total Liabilities And Equity | $42,019 | $37,481 | $22,140 | $27,153 | $31,671 |